Schizophrenia Flashcards
(36 cards)
What is SP? (4)
-long duration -Delusions and hallucinations -Anhedonia, social withdrawral -Cognitive symptoms
Prevalence of SP
1%
How many patients don’t respond?
30%
Carlsson (1963)
Antipsychotic drugs reduce dopaminergic signalling. Enhanced accumulation of the metabolites of dopamine in rat brains, measured by chromatography
Seeman (1975)
PET studies using radiotracer for D2 receptor. Clinical efficacy of most antipsychotics directly correlates with their ability to bind D2 receptor.
Abi-Dargham (1998)
In vivo radiotracer assay for D2. After challenge with amphetamine, dopamine transmission increased more in SP patients than in healthy controls
Kapur
Argues that dopamines role in providing salience to stimuli in out environment could require individuals to explain experience of aberrant salience through development of delusional constructs
Why not dopamine in striatum?
Typical antipsychotics have little effect on - symptoms
Silfstein (2015)
In vivo imaging of dopamine release in PFC through PET scanning. Deficit in capacity for dopamine release in DL PFC in SP patients.
Evidence for PFC dopamine
-Silfstein (2015) -Pycock (1980s) -Human frontal lesions
Pycock (1980s)
link excess dopamine in striatum with low concs in PFC. Lesions in PFC dopaminergic neurons lead to increased dopamine and D2R density in the striatum.
Glutamate genes related to SP
-Dysbindin (uptake of glutamate into synaptic vesicles) -Neuregulin 1 (recruitment of NMDA receptors to synapse)
Pleiomorphic roles of Neuregulin 1
-Interneuron migration -Myelination
Weinberger
Mechanistic understanding of glutamate. NMDA hypo-function in cortical interneurons, leading to hyperexcitability of pyramidal neurons, acting on dopaminergic neurons. Increase stimulation of striatum and decrease stimulation of the PFC.
Mohn (1999)
Mice expressing 5% of normal levels of the NR1 subunit of the NMDAR show behavioural alterations - increased motor activity and stereotypy. Ameliorated through action of antipsychotics.
Belforte (2010)
transgenic mice with NR1 subunit selectively eliminated in around half of cortical neurons early in postnatal development show behavioural defecits in mating, nest-building and novelty-induced hyperlocomotion.
Why not model animals?
-Symptoms hard to demonstrate in models -No known molecular or cellular abnormalities that can demonstrate SP phenotype.
What receptor does clozapine act at?
Inverse agonist on 5-HT2C receptors for serotonin.
Simpson (2011)
transgenic mouse line with increased striatal specific D2R density as model. Reversible increase in 5-HT2C receptor expression. Low level of motivation overcome by antagonist to receptor, not achieved by D2R blockade.
Environmental factors increasing SP
-maternal malnutrition -maternal infection -Obstetric complications
Imaging studies in support of neurodevelopmental hypothesis show..
enlarged ventricles, loss of cortical volume. Present at onset of SP yet PM no evidence of ND
Jakob (1986)
Abnormalities in laminar organisation of neurons in majority of 64 Sz patients, with no evidence of gliosis. Implies changes occur before late pregnancy.
Straub (2002)
Genetic linkage analysis on high-density irish pedigrees showing dysbindin in SP.
What is the etymology of ‘schizophrenia’
schizo - split phrenia - mind
